EuroMAbNet: European Monoclonal Antibodies NetworkEuroMAbNet. European Monoclonal Antibodies Network

☰ Menu

2nd Antibody Validation Workshop 26th of May 2017

EuroMAbNet is providing excellent training in Antibody Validation.

EuroMabNet workshop on Antibody Validation will bring together highly specialized scientists in antibody technology with PhD students and young scientists who use antibodies in their research. It will provide a set of criteria and recommendations that will help researchers to select the most effective mAbs from those available in the market and provide the strategic guidance needed to perform any essential antibody validation. Workshop on Antibody Validation will take place in Madrid (Spain) the 26th of May 2017.

Spanish National Cancer Research Centre (CNIO)

9th Euromabnet meeting 5th and 6th of October 2017

Since 2007 the EuroMAbNet is organising annual meetings of experts in the different disciplines of antibody production and validation across Europe. These meetings provide an arena in which participants can exchange knowledge, share cutting-edge methodology and create common strategies to standardise and improve antibody production. This year EuroMAbNet will take place in Pécs (Hungary) the 5th and 6th of October, 2017.

University of Pécs

The first European network

EuroMAbNet represents the first European network of laboratories linked to academic Institutions, each having an internationally recognized reputation in the production and use of monoclonal antibodies. Read more...

Exchange of knowledge

EuroMAbNet provide an arena in which people working in the field of monoclonal antibody production and technology can exchange knowledge, share the most up-to-date methodology and create common strategies to both standardize and improve the production of properly validated monoclonal antibodies. Read more...

Antibody validation article and guidelines

EuroMAbNet has recently published a position paper, and Ab validation guidelines providing criteria and recommendations aimed at helping researchers to select the most effective mAbs from those available in the market, and the guidance needed to perform effective antibody validation. Read more...